Lawmakers are pushing bills that would throw people in jail for putting the word "meat" or similar terms on the label. It's a bad move for so many reasons.
Following up on their joint statement from last year, the FDA and USDA have released a Formal Announcement spelling out their joint oversight of cell-based meat and poultry production in the United States.
Plant-based milks now command 13% of the retail market, so cow's milk producers are calling for censorship of terms like "almond milk." GFI's policy team defends plant-based milk in our official filing with the FDA.
Together with Avant Meats, BlueNalu, Finless Foods, Mosa Meat, New Age Meats, Seafuture, and SuperMeat, we lay out the need for clear and fair regulatory structures clean (aka cell-based) meat.
GFI Policy Director Jessica Almy discusses pivotal developments in plant-based and cell-based meat regulation, illuminates key work by the GFI policy team along the way, and lays out what still needs to be done.
Mark the date: November 16, 2018 was the day that clean/cell-based meat's path to market became much clearer in the United States. On that day, the FDA and USDA announced details of how they will oversee clean/cell-based meat from cows, pigs, chickens, and turkeys.
USDA and FDA held a joint public meeting on to advance the conversation around clean meat regulation. GFI advocated firmly for a fair regulatory path to market under the existing regulatory structures. Our friends at JUST, Finless Foods, BlueNalu, UPSIDE Foods, and many others joined the conversation as well.
We weigh in on FDA's initiative to review its regulatory approach to nutrition and improve standards of identity, labeling claims, and ingredient information in the 21st Century.
We partnered with BlueNalu, Mosa Meat, Seafuture, and SuperMeat to share our thoughts on clean meat regulation with the FDA.